128 results
Page 5 of 7
6-K
EX-99.2
bwllwy3l7p
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
skh1s7qgjfk8
6 Nov 20
Current report (foreign)
10:06am
6-K
EX-99.1
nuk 3a8qfb
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.1
ccjjdypiz4s y0uv7
27 Oct 20
Current report (foreign)
12:13pm
6-K
EX-99.1
ahuier6
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
6-K
EX-99.1
0y9vy4qr6 5d
13 Oct 20
Current report (foreign)
6:15am
S-8
EX-4.1
w7que5rv
9 Oct 20
Registration of securities for employees
4:32pm
6-K
EX-99.1
wrsp4pj yk747tuz0z
30 Sep 20
Galapagos announces first dosing with Toledo compound GLPG3970 in psoriasis trial
6:00am
6-K
EX-99.1
ryzra
28 Sep 20
Current report (foreign)
6:00am
6-K
EX-99.1
g3hamzi1s ccyvb
25 Sep 20
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
6:05am
6-K
EX-99.1
gwymw981vds
26 Aug 20
Galapagos to present new insights in IPF and related clinical developments at the European Respiratory Society Congress
6:37am
6-K
EX-99.1
vmxfur1betvsjd
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.1
sz37rfq lh
13 Aug 20
Current report (foreign)
9:42am
6-K
EX-99.2
pazgn
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
vtmml4x2qp 67uux8e
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.2
ii6jaus9ydief6j
11 May 20
Current report (foreign)
4:05pm
6-K
EX-99.2
2iapd2l05lmzr3lgy7ja
25 Oct 19
Solid third quarter 2019 performance with strong balance sheet for continued R&D growth
5:00pm
6-K
EX-99.2
h1a5osbl
20 Sep 19
Current report (foreign)
4:07pm